Business Development

Business Development

Anesiva is focused on developing drugs that target unmet medical needs in pain management. We are currently seeking a partner to advance the development of our late-stage product Adlea™ for the treatment of post-operative pain associated with orthopedic surgeries. Adlea™ has the potential for further development for the treatment of pain for the following:

  • Osteoarthritis
  • Post-operative pain associated with other types of procedures (e.g., general surgery)
  • Musculoskeletal pain
  • Neuropathic pain
For more information regarding the Adlea™ opportunity, please contact Business Development at bd@anesiva.com.

BUSINESS DEVELOPMENT CONTACT

John Donovan, MD, MBA
Executive Director, Business Development
Anesiva, Inc.
400 Oyster Point Blvd, Suite #502
South San Francisco, CA 94080
Fax: 650-624-7540